Our results show that miR-145 levels decrease during EOC progression and that miR-145 upregulation decreases cell proliferation and c-MYC and VEGF levels in ovarian cells, as well as tumor size and the malignant presence of ascites in a mouse model. This evidence concerns the gene MYC and neoplasm.